https://european-biotechnology.net/wp-content/uploads/2025/12/Orano-Meds-production-facility-e1764923942582-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-12-05 08:39:08 2025-12-05 08:39:08 Orano Med and Roche ink clincical distribution deal in radiopharmacy
https://european-biotechnology.net/wp-content/uploads/2025/12/Jacob-Jensen-the-Minister-for-Food-Agriculture-and-Fisheries_fvm.dk_-e1764835956239-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-12-04 09:31:47 2025-12-04 09:31:47 EU trilogue sets clear path for new genomic techniques
https://european-biotechnology.net/wp-content/uploads/2025/12/AP-117th-Congress-Official-Headshot-1-scaled-1-e1764772385163-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-12-03 14:33:37 2025-12-03 14:33:37 Topical DHT blockade demonstrates significant efficacy
https://european-biotechnology.net/wp-content/uploads/2025/12/Keir-Starmer-UK-Prime-Minister-e1764664824352.jpg
262
465
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-12-02 08:40:40 2025-12-02 08:40:40 UK hikes drug prices after pharma exodus
https://european-biotechnology.net/wp-content/uploads/2025/12/EIB-Oscar-Romano-e1764601497811-1030x581-1.jpg
581
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-12-01 16:00:37 2025-12-01 16:00:37 Angelini Ventures and EIB launch joint start-up financing
https://european-biotechnology.net/wp-content/uploads/2025/11/EU_Bioeconomy_Strategy2025_1313742648_sHdBcJFWOp5h9nxyIv92FNzEpGKM0aj1-e1764332108995.webp
543
967
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-11-28 12:16:46 2025-11-28 12:16:46 EU Commission presents new bioeconomy strategy
https://european-biotechnology.net/wp-content/uploads/2025/12/afyren-web.jpeg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-11-27 15:05:20 2025-12-03 10:02:03 € 23 Mio: Afyren successful in capital increase
https://european-biotechnology.net/wp-content/uploads/2025/11/AdobeStock_567963308-1030x579-1.jpeg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-11-27 11:55:51 2025-11-27 11:55:51 Ventuno Biotech Secures €3m to Power Next-Gen Cancer Immunotherapies
https://european-biotechnology.net/wp-content/uploads/2025/11/Alzheimer_semaglutide_483897781_059ZuRgXrKJ8ubHxTiCeiYY6BOdGSl4Z-e1764149601345.jpg
433
653
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-11-26 09:33:43 2025-11-26 09:33:43 Novo Nordisk’s semaglutide fails in Alzheimer’s
https://european-biotechnology.net/wp-content/uploads/2025/11/Gilead-Sciences-HQ-e1764058680645.png
322
572
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk 2025-11-25 08:18:21 2025-11-25 08:18:21 Gilead acquires Sprint Bioscience TREX1 programme
Scroll to top
Scroll to top
Scroll to top
